Tenecteplase in Ischemic Stroke: Challenge and Opportunity

PURPOSE OF REVIEW: Intravenous thrombolysis is the first-line therapy for ischemic stroke, and alteplase has been used as an intravenous thrombolysis drug for over 20 years. However, considering its low rate of recanalization and risk of intracerebral hemorrhage, alteplase may not be the optimal thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangshuo, Wang, Chuanying, Wang, Shang, Xiong, Yunyun, Zhao, Xingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109727/
https://www.ncbi.nlm.nih.gov/pubmed/35586365
http://dx.doi.org/10.2147/NDT.S360967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109727/
https://www.ncbi.nlm.nih.gov/pubmed/35586365
http://dx.doi.org/10.2147/NDT.S360967

Ejemplares similares